Passaro, A ;
Leighl, N ;
Blackhall, F...
Passaro , A , Leighl , N , Blackhall , F , Popat , S , Kerr , K , Ahn , M J , Arcila , M E , Arrieta , O , Planchard , D , de Marinis , F , Dingemans , A M , Dziadziuszko , R , Faivre-Finn , C , Feldman , J , Felip , E , Curigliano , G , Herbst , R , Jänne , P A , John , T , Mitsudomi , T , Mok , T , Normanno , N , Paz-Ares , L , Ramalingam , S , Sequist , L , Vansteenkiste , J , Wistuba , I I , Wolf , J , Wu , Y L , Yang , S R , Yang , J C H , Yatabe , Y , Pentheroudakis , G & Peters , S 2022 , ' ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer ' , Annals of Oncology , vol. 33 , no. 5 , pp. 466-487 . https://doi.org/10.1016/j.annonc.2022.02.003.
,
2022
